NEW YORK (GenomeWeb News) – Researchers from the University of Montreal's Hospital Center (CHUM) will head a pan-Canadian study to discover biomarkers for prostate cancer treatment that is funded by C$4 million (US$3.9 million) from the Terry Fox Foundation and the Canadian Partnership Against Cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.